BANK OF AMERICA CORP /DE/ - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$433,946
-22.4%
188,672
+23.2%
0.00%
Q2 2023$559,096
-6.5%
153,177
-8.5%
0.00%
Q1 2023$597,957
+116.2%
167,495
+72.6%
0.00%
Q4 2022$276,547
+9.3%
97,034
-14.5%
0.00%
Q3 2022$253,000
+289.2%
113,512
+331.4%
0.00%
Q2 2022$65,000
-85.5%
26,311
-71.4%
0.00%
Q1 2022$449,000
-65.5%
91,901
-20.1%
0.00%
Q4 2021$1,301,000
+180.4%
115,070
+261.0%
0.00%
Q3 2021$464,000
+32.6%
31,877
+6.1%
0.00%
Q2 2021$350,000
-35.4%
30,041
-32.4%
0.00%
Q1 2021$542,000
+52.2%
44,437
+56.3%
0.00%
Q4 2020$356,000
-27.5%
28,427
-12.9%
0.00%
Q3 2020$491,000
-40.6%
32,637
-3.3%
0.00%
Q2 2020$827,000
+221.8%
33,737
+86.6%
0.00%
Q1 2020$257,000
+32.5%
18,084
+47.7%
0.00%
Q4 2019$194,000
+74.8%
12,247
-6.5%
0.00%
Q3 2019$111,000
-0.9%
13,103
+4.9%
0.00%
Q2 2019$112,000
+51.4%
12,493
+32.0%
0.00%
Q1 2019$74,000
+7.2%
9,464
-35.7%
0.00%
Q4 2018$69,000
+91.7%
14,724
+268.8%
0.00%
Q3 2018$36,000
-2.7%
3,992
+30.8%
0.00%
Q2 2018$37,000
+311.1%
3,052
+361.7%
0.00%
Q1 2018$9,0006610.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,915,219$23,959,0005.70%
Prosight Management, LP 906,569$11,341,0005.24%
P.A.W. CAPITAL CORP 140,000$1,751,0001.54%
Voss Capital, LLC 220,714$2,761,0001.39%
Robertson Stephens Wealth Management, LLC 484,000$6,054,0001.26%
Slate Path Capital LP 1,483,619$18,560,0001.00%
Nantahala Capital Management 2,506,772$31,360,0000.97%
PRECEPT MANAGEMENT LLC 150,000$1,877,0000.76%
SANDERS MORRIS HARRIS LLC 193,591$2,449,0000.56%
Rock Creek Group, LP 100,014$1,251,0000.51%
View complete list of CUE BIOPHARMA INC shareholders